Deliberate self-harm and antidepressant drugs. Investigation of a possible link.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 11102331.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
It is not clear if the frequency of deliberate self-harm (DSH) is the same in patients taking different pharmacological classes of antidepressant drugs. To compare the frequency of DSH in patients who had been prescribed a tricyclic antidepressant (TCA) or a selective serotonin reuptake inhibitor (SSRI) prior to the DSH event. This was a prospective study in 2776 consecutive DSH cases attending an accident and emergency department. The incidence of DSH in TCA-treated cases and SSRI-treated cases is expressed as number of DSH events per 10 000 prescriptions of each antidepressant. Significantly more DSH events occurred following the prescription of an SSRI than that of a TCA (P<0.001). The occurrence of DSH was highest with fluoxetine and lowest with amitriptyline. Merely prescribing safer-in-overdose antidepressants is unlikely to reduce the overall morbidity from DSH.
Medical subject headings
- Antidepressive Agents, Tricyclic
- Self Mutilation
- Selective Serotonin Reuptake Inhibitors